Sort
21,281 grants matching “influenza”
Host genetic determinants of diversity in viral-induced neuropathology
$320,520Candice L. Brinkmeyer-Langford · Texas A&M University · R01 · FY2020 · NS
RUI: L-Alanine Biosynthesis in Escherichia Coli
$320,493William Whalen · Xavier University Of Louisiana · · FY2002 · BIO
Virus-Host Interactions that Lead to Epilepsy
$320,491Robert S Fujinami · University Of Utah · R01 · FY2012 · NS
Receptor Diversity in Recognition of Influenza HA
$320,473Wistar Institute · R01 · FY2003 · AI
Overcoming Immunosenescence by Nanoparticle-Mediated Activation
$320,433Kam W Leong · Columbia University Health Sciences · R01 · FY2016 · AI
High-Expression, Rapid Production of Influenza Vaccines in Cell-Based Systems
$320,430Vitaliy Gavrilyuk · Cdi Bioscience, Inc. · R01 · FY2011 · AI
Viral Mediated Type I Interferon Induction
$320,420Genhong Cheng · University Of California Los Angeles · R01 · FY2010 · AI
Host genetic determinants of diversity in viral-induced neuropathology
$320,305Candice L. Brinkmeyer-Langford · Texas A&M University · R01 · FY2021 · NS
Fusion Inhibitors of Influenza Virus
$320,288Ming Luo · University Of Alabama At Birmingham · R01 · FY2013 · AI
Enabling Technology to Screen and Quantify Sialylated Structures for Activity Against Viral Enzymes and Receptors
$320,174Lisa A Holland · West Virginia University · R01 · FY2021 · GM
Mechanisms of Enzyme Regulation by Viperin in the Cellular Antiviral Response
$320,165E Neil Marsh · University Of Michigan At Ann Arbor · R01 · FY2021 · GM
Host genetic determinants of diversity in viral-induced neuropathology
$320,078Candice L. Brinkmeyer-Langford · Texas A&M University · R01 · FY2022 · NS
Understanding and Controlling Viral Membrane Fusion Proteins
$320,000Eric Boder · University Of Tennessee Knoxville · · FY2013 · ENG
Sustaining Influenza Surveillance Networks and Response to Seasonal and Pandemic
$320,000Maria Lopes De Carvalho · Fiotec · U51 · FY2013 · IP
High-throughput screening for novel adjuvant discovery for vaccines against influenza virus
$320,000Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2017 · AI
Population-based Surveillance for Zoonotic Influenza A
$320,000University Of Iowa · R21 · FY2005 · AI
SUSTAINING AND ENHANCEMENT OF INFLUENZA SURVEILLANCE AND RESPONSE
$320,000Anna Sominina · Fgbu Nii Grippa Minzdrava Rossii · U51 · FY2014 · IP
DEVELOPMENT OF NATIONAL INFLUENZA SENTINEL SURVEILLANCE SYSTEM IN VIETNAM
$320,000Nguyen Tran Hien · National Institute Hygiene/Epidemiology · U51 · FY2011 · IP
DEVELOPMENT OF THE HBCAG AS A VACCINE CARRIER PLATFORM
$320,000Vaccine Research Institute Of San Diego · R01 · FY2002 · AI
NIGERIA MINISTRY OF HEALTH SEASONAL AND PANDEMIC INFLUENZA CONTROL PROGRAM
$320,000Adebayo Abel Adedeji · Federal Ministry Of Health Nigeria · U51 · FY2014 · IP
DEVELOPMENT OF THE HBCAG AS A VACCINE CARRIER PLATFORM
$320,000Vaccine Research Institute Of San Diego · R01 · FY2001 · AI
MOLECULAR MECHANISMS OF VIRAL MEMBRANE FUSION PROTEINS
$319,960University Of Virginia Charlottesville · R01 · FY2004 · AI
VTEU: Phase I Clinical Trial of an Influenza Vaccine
$319,849Patricia Winakur · University Of Iowa · N01 · FY2016 · AI
Epitranscriptomic modification of HIV-1 transcripts: Effects of drugs of abuse
$319,834Bryan R. Cullen · Duke University · R01 · FY2018 · DA
Simultaneously boosting both humoral and cellular immunity following vaccination
$319,800Jie Sun · Indiana University Indianapolis · R01 · FY2015 · AG